131 related articles for article (PubMed ID: 3781482)
1. Growth hormone therapy for patients with Turner's syndrome.
Singer-Granick C; Lee PA; Foley TP; Becker DJ
Horm Res; 1986; 24(4):246-50. PubMed ID: 3781482
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone treatment in girls with Turner's syndrome. A review of the literature.
Wilton P
Acta Paediatr Scand; 1987 Mar; 76(2):193-200. PubMed ID: 3296625
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters.
Haeusler G; Frisch H
Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078
[TBL] [Abstract][Full Text] [Related]
4. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
5. Growth response relationship between growth hormone dose and short term growth in patients with Turner's syndrome.
Ross JL; Long LM; Skerda M; Cassorla F; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1986 Oct; 63(4):1028-30. PubMed ID: 3745402
[TBL] [Abstract][Full Text] [Related]
6. Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome.
Kamp GA; Kuilboer MM; Wynne HJ; Rongen-Westerlaken C; Johnson ML; Veldhuis JD; Wit JM
J Clin Endocrinol Metab; 1993 Jun; 76(6):1604-9. PubMed ID: 8501169
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute high dose and chronic low dose estrogen on plasma somatomedin-C and growth in patients with Turner's syndrome.
Copeland KC
J Clin Endocrinol Metab; 1988 Jun; 66(6):1278-82. PubMed ID: 3372687
[TBL] [Abstract][Full Text] [Related]
8. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
9. Decreased growth hormone response to growth hormone-releasing hormone in Turner's syndrome: relation to body weight and adiposity.
Reiter JC; Craen M; Van Vliet G
Acta Endocrinol (Copenh); 1991 Jul; 125(1):38-42. PubMed ID: 1872123
[TBL] [Abstract][Full Text] [Related]
10. The interaction of growth hormone, somatomedin and oestrogen in patients with Turner's syndrome.
Saenger P; Schwartz E; Wiedemann E; Levine LS; Tsai M; New MI
Acta Endocrinol (Copenh); 1976 Jan; 81(1):9-18. PubMed ID: 946143
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment in Turner's syndrome.
Takano K; Hizuka N; Shizume K
Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 80 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for one year: the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
Takano K; Shizume K; Hibi I
Endocrinol Jpn; 1989 Apr; 36(2):253-60. PubMed ID: 2673750
[TBL] [Abstract][Full Text] [Related]
13. Methionyl human growth hormone in Turner's syndrome.
Rongen-Westerlaken C; Wit JM; Drop SL; Otten BJ; Oostdijk W; Waal HA; Gons MH; Bot A; Van den Brande JL
Arch Dis Child; 1988 Oct; 63(10):1211-7. PubMed ID: 3196048
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
Rosenfeld RG
Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
[TBL] [Abstract][Full Text] [Related]
16. Treatment of 94 patients with Turner's syndrome with recombinant human growth hormone (SM-9500) for two years--the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
Takano K; Shizume K; Hibi I
Endocrinol Jpn; 1989 Aug; 36(4):569-78. PubMed ID: 2684622
[TBL] [Abstract][Full Text] [Related]
17. Glucose turnover and insulin clearance after growth hormone treatment in girls with Turner's syndrome.
Monti LD; Brambilla P; Caumo A; Magni F; Omati S; Nizzoli G; di Natale B; Galli-Kienle M; Cobelli C; Chiumello G; Pozza G
Metabolism; 1997 Dec; 46(12):1482-8. PubMed ID: 9439548
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive somatomedin B in acromegaly and in Turner's syndrome.
Benker G; Spira G; Zäh W; Tharandt L; Hackenberg K; Reinwein D
Clin Endocrinol (Oxf); 1979 Oct; 11(4):357-65. PubMed ID: 519875
[TBL] [Abstract][Full Text] [Related]
19. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].
Naeraa RW; Nielsen J; Kastrup KW
Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
